Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹172 Cr
Revenue (TTM)
₹104 Cr
Net Profit (TTM)
₹14 Cr
ROE
24.6 %
ROCE
26.9 %
P/E Ratio
12.7
P/B Ratio
1.8
Industry P/E
35.17
EV/EBITDA
10.1
Div. Yield
0 %
Debt to Equity
0.4
Book Value
₹49.9
EPS
₹8.3
Face value
10
Shares outstanding
16,387,200
CFO
₹-11.93 Cr
EBITDA
₹47.27 Cr
Net Profit
₹33.47 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Quest Laboratories
| -4.7 | -13.1 | -5.5 | -1.2 | -- | -- | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
|---|---|
|
Quest Laboratories
| -6.9 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Quest Laboratories
|
105.0 | 172.0 | 104.0 | 13.6 | -- | 24.6 | 12.7 | 1.8 |
| 2,110.2 | 17,282.6 | 1,215.1 | 284.8 | 28.7 | 21.1 | 60.2 | 11.4 | |
| 656.2 | 12,893.6 | 7,266.8 | 627.5 | 11.9 | 12.6 | 20.5 | 2.4 | |
| 613.6 | 15,214.7 | 5,092.5 | 545.5 | 15.9 | 14.1 | 27.9 | 3.7 | |
| 839.3 | 13,375.6 | 7,918.4 | 429.9 | 10.7 | 7.2 | 30.9 | 2.0 | |
| 1,027.6 | 18,409.8 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11.8 | 2.1 | |
| 1,404.5 | 16,092.2 | 1,419.3 | 20.1 | 8.4 | 0.5 | 800.5 | 2.8 | |
| 142.2 | 18,882.0 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.4 | |
| 391.1 | 15,752.9 | 3,720.2 | 352.1 | 13.7 | 8.2 | 44.7 | 3.3 | |
| 1,271.5 | 20,670.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 939.6 | 4.5 |
No Review & Analysis are available.
--
Incorporated
1998
Chairman
--
Managing Director
Anil Kumar Sabarwal
Headquarters
Dhar, Madhya Pradesh
Website
Looking for more details about Quest Laboratories Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Quest Laboratories Ltd is ₹104.95 (NSE) as of 02-Apr-2026 IST. Quest Laboratories Ltd has given a return of -1.22% in the last 1 years.
The P/E ratio of Quest Laboratories Ltd is 12.68 times as on 02-Apr-2026, a 64 discount to its peers’ median range of 35.17 times.
The P/B ratio of Quest Laboratories Ltd is 1.83 times as on 02-Apr-2026, a 43 discount to its peers’ median range of 3.21 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
12.38
|
2.05
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Quest Laboratories Ltd are Rs 140.35 and Rs 75.15 as of 03-Apr-2026.
Quest Laboratories Ltd has a market capitalisation of ₹ 172 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Quest Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹2.60
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.